Aurobindo Pharma completes acquisition of balance 49% stake of GLS Pharma

28 Oct 2024 Evaluate

Aurobindo Pharma has completed acquisition of balance 49% of equity shares of GLS Pharma. Earlier, the company had entered into a binding agreement on September 18, 2024, with GLS Pharma, a subsidiary of the Company and its promoters for acquisition of balance 5,90,361 equity shares of Rs 10 each (49% of GLS Pharma) for a purchase consideration of Rs 22.5 crore.

The aforementioned acquisition has been completed on October 25, 2024 and GLS has become a wholly owned subsidiary of the company.

Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.


Aurobindo Pharma Share Price

1220.20 -27.70 (-2.22%)
21-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.65
Dr. Reddys Lab 1194.55
Cipla 1465.65
Lupin 2043.30
Zydus Lifesciences 944.25
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.